글로벌 부신피질자극호르몬(ACTH) 시장 – 2029년까지의 산업 동향 및 예측

 시장 분석 및 규모

최근 몇 년 동안 부신피질자극호르몬(ACTH) 시장은 예측 기간 동안 빠르게 성장할 것으로 예상됩니다. COVID-19 팬데믹은 계획, 준비 및 협업을 통해 미국 전체 의료 시스템에서 관리하고 있습니다. 부신피질자극호르몬(ACTH) 산업의 제조업체는 지속적인 공급망을 유지하기 위해 고위험 환자와 호흡기 질환이 있는 환자의 치료 습관을 이해하려고 시도하고 있습니다. 제조업체는 전염병 동안 경제를 유지하기 위해 응급 치료 센터, 약국 내 리테일 클리닉, 직장 클리닉과 함께 견고한 공급망을 개발하고 있습니다. 응급실은 이미 과부하 상태이기 때문에 이러한 장소는 습지처럼 작동하여 아픈 환자와 건강한 환자의 범람을 일부 흡수할 수 있습니다.

Data Bridge Market Research는 부신피질자극호르몬(ACTH)? 시장이 2021년에 13억 8천만 달러 규모였으며 2029년까지 22억 달러에 도달할 것으로 예상되며 2022년에서 2029년까지의 예측 기간 동안 6.00%의 CAGR을 기록할 것으로 분석했습니다. Data Bridge Market Research 팀이 큐레이팅한 시장 보고서에는 심층적인 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크가 포함되어 있습니다.

시장 정의

뇌하수체는 뇌의 바닥 근처에 있는 작은 샘으로, 부신피질자극호르몬(ACTH)을 생성합니다. 부신피질자극호르몬(ACTH)은 또 다른 호르몬인 코르티솔의 생성을 조절합니다. 신장 위에 위치한 두 개의 작은 샘인 부신은 코르티솔을 생성합니다.

보고 범위 및 시장 세분화

Adrenocorticotropic Hormone (ACTH)? Market Dynamics

Drivers

• Rise in the use of adrenocorticotropic hormone (ACTH) products

Over the last few years, the use of adrenocorticotropic hormone (ACTH) has expanded dramatically. The adrenocorticotropic hormone is currently used to treat nephrotic syndrome, ophthalmology, rheumatology, Addison disease, Cushing syndrome, and Cushing illness, among other conditions. The increased use of adrenocorticotropic hormone (ACTH) products produces a tremendous demand for these goods and acts as a market driver.

• Increasing investment for healthcare infrastructure

Another significant factor influencing the growth rate of adrenocorticotropic hormone (ACTH)? market is the rising healthcare expenditure which helps in improving its infrastructure.

Furthermore, rising initiatives by public and private organizations to spread awareness will expand the adrenocorticotropic hormone (ACTH)? market. Additionally, high disposable income and surging prevalence of multiple sclerosis and infantile spasms will expand the adrenocorticotropic hormone (ACTH)? market. Along with this, rising incidences of stress and anxiety among people and favourable reimbursement policies will enhance the market's growth rate.

Opportunities

• Increase in the number of research and development activities       

Moreover, the market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the adrenocorticotropic hormone (ACTH)? market growth. Rising approvals and launches with adrenocorticotropic hormone (ACTH) will further propel the market’s growth rate.

Moreover, rising investment for the development of advanced technologies and increase in the number of emerging markets will further provide beneficial opportunities for the adrenocorticotropic hormone (ACTH)? market growth during the forecast period.

Restraints/Challenges

On the other hand, the high cost associated with the drug development and distribution? will obstruct the growth rate of market. The dearth of skilled professionals and lack of healthcare infrastructure in developing economies will challenge the adrenocorticotropic hormone (ACTH)? market. Additionally, side effects of adrenocorticotropic hormone (ACTH)? and lack of awareness will act as market restraints and further impede the market's growth rate during the forecast period of 2022-2029.

This adrenocorticotropic hormone (ACTH)? market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the adrenocorticotropic hormone (ACTH)? market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Patient Epidemiology Analysis

Adrenocorticotropic hormone (ACTH)? market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

COVID-19 Impact on Adrenocorticotropic Hormone (ACTH)? Market

Since its emergence in December 2019, the COVID-19  virus has spread to nearly every country on the planet, prompting the World Health Organization (WHO) to declare it a public health emergency. COVID-19, a new coronavirus, was identified as the causal agent in the pneumonia cases. This can be ascribed to severe disruptions in their respective manufacturing and supply-chain operations, resulting from multiple precautionary lockdowns and other limitations imposed by governments all over the world. The inkjet printers market is no exception. Furthermore, consumer preferences has decreased as people are now much more concentrated on removing non-essential expenses from their budgets as the wider economic situation of most people has been adversely impacted by this outbreak. Over the forecast period, the aforementioned factors are likely to have a negative impact on the adrenocorticotropic hormone (ACTH) market's revenue trajectory.

Global Adrenocorticotropic Hormone (ACTH)? Market Scope

The adrenocorticotropic hormone (ACTH)? market is segmented on the basis of source, application, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Source

• Natural
• Synthetic

On the basis of source, the global adrenocorticotropic hormone (ACTH)market is segmented into natural, and synthetic.

Application

• Rheumatology
• Neurology
• Nephrotic Syndrome
• Ophthalmology
• Others

On the basis of application, the global adrenocorticotropic hormone (ACTH)market is segmented into rheumatology, neurology, nephrotic syndrome, ophthalmology and others.

End-Users

• Hospitals
• Specialty Clinics
• Homecare
• Others

On the basis of end-users, the adrenocorticotropic hormone (ACTH)? market is segmented into hospitals, specialty clinics, homecare and others.

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others

On the basis of distribution channel, the adrenocorticotropic hormone (ACTH)? market has also been segmented into hospital pharmacy, retail pharmacy, online pharmacy and others.

Adrenocorticotropic Hormone (ACTH)? Market Regional Analysis/Insights

The adrenocorticotropic hormone (ACTH)? market is analysed and market size insights and trends are provided by country, source, application, end-users and distribution channel as referenced above.

The countries covered in the adrenocorticotropic hormone (ACTH)? market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America dominates the adrenocorticotropic hormone (ACTH) market because of the increase in the number of research and development activities in this region. Additionally, growing presence of major key players will further propel the market’s growth rate in this region.

Asia-Pacific is expected to grow during the forecast period of 2022 to 2029 due to rising healthcare expenditure and increasing government initiatives to improve healthcare infrastructure in this region.

보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 트렌드에 영향을 미치는 규제 변화를 제공합니다. 다운스트림 및 업스트림 가치 사슬 분석, 기술 트렌드 및 포터의 5가지 힘 분석, 사례 연구와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 몇 가지 포인터입니다. 또한 글로벌 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 국내 관세 및 무역 경로의 영향은 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.   

경쟁 환경 및 부신피질자극호르몬(ACTH) ? 시장 점유율 분석

아드레노코르티코트로핀 호르몬(ACTH)? 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보에는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우위가 있습니다. 제공된 위의 데이터 포인트는 아드레노코르티코트로핀 호르몬(ACTH)? 시장과 관련된 회사의 초점에만 관련이 있습니다.

부신피질자극호르몬(ACTH) 시장에서 활동하는 주요 업체는 다음과 같습니다.

• 파이저 주식회사(미국)
• GlaxoSmithKline plc (영국)
• 머크앤코(미국)
• 노바티스 AG(스위스)
• 히크마 제약(영국)
• Avantor, Inc. (미국)
• 페링 BV(스위스)
• Viatris, Inc. (미국)
• 머크 KGaA(독일)

SKU-68078